PathogenDx D3 Array UTI
PathogenDx has launched its D3 Array UTI, a multiplexed PCR-based test that detects 26 pathogens and 12 antibiotic resistance genes. Clinicians can use the test to help provide rapid urinary tract infection treatment, Scottsdale, Arizona-based PathogenDx said. The test leverages the firm's Dynamic Dimensional Detection (D3) Array technology featuring a 3D lattice-like architecture deposited on a substrate, allowing targets to move through the structure and bind to probes at room temperature with high sensitivity and specificity. D3 Array UTI utilizes a 96-well plate, while data analysis and reporting is automated via PathogenDx's Augury proprietary cloud-based data analysis and management tool.